Amerimmune Pharmaceuticals is Biotechnology in United States that focus on Immune Deficiency Syndrome business. Founded in 1986. They cover business area such as developer, marketer, monoclonal antibody, patient, Human Immunodeficiency Virus, Acquired Immune Deficiency Syndrome, certain adhesion molecule.
1986
( 38 years old in 2024 )
Immune Deficiency Syndrome
-
2325A Renaissance Drive
Las Vegas, NV 89119
United States
Private
developermarketermonoclonal antibodypatientHuman Immunodeficiency VirusAcquired Immune Deficiency Syndromecertain adhesion molecule
* We use standard office opening hours in near Amerimmune Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Amerimmune Pharmaceuticals is Biotechnology business from United States that founded in 1986 (38 years old in 2024), Amerimmune Pharmaceuticals business is focusing on Immune Deficiency Syndrome.
Amerimmune Pharmaceuticals headquarter office and corporate office address is located in 2325A Renaissance Drive Las Vegas, NV 89119 United States.
Amerimmune Pharmaceuticals was founded in United States.
In 2024, Amerimmune Pharmaceuticals is currently focus on Immune Deficiency Syndrome sector.
Above is snippet of Google Trends for "Immune Deficiency Syndrome" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Amerimmune Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.